Description
BSE permits trading of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
Summary
BSE has announced the listing and trading permission for 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were previously kept in abeyance. These shares will be available for trading from Monday, September 1, 2025.
Key Points
- 1000 bonus equity shares of Rs. 1/- each kept in abeyance are now listed
- Shares belong to Ipca Laboratories Ltd (Scrip Code: 524494)
- ISIN: INE571A01038
- Distinctive numbers range from 1171453 to 1172452
- Trading permitted from September 1, 2025
Regulatory Changes
No regulatory changes introduced. This is a routine listing of bonus shares that were previously held in abeyance.
Compliance Requirements
Trading members are informed about the availability of these securities for trading. No specific compliance actions required beyond normal trading procedures.
Important Dates
- Trading Commencement: Monday, September 1, 2025
- Notice Date: August 29, 2025
Impact Assessment
Minimal market impact expected as this involves only 1000 bonus shares being released from abeyance. The small quantity is unlikely to affect the stock’s trading dynamics or market capitalization significantly.
Impact Justification
Small number of bonus shares (1000) being listed from abeyance has minimal market impact